Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 11-I-0164 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Background:
- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical trials at the Vaccine Research Center that evaluate investigational vaccines, monoclonal antibodies, and injection devices. The VRC conducts studies that will allow researchers to better understand the immune system and how vaccines and monoclonal antibodies work.
Objectives:
- To screen healthy volunteers for clinical trials at the NIAID VRC.
Eligibility:
- Healthy people between 18 and 60 years of age. They must be available to take part in clinical trials and be able to provide blood for research studies.
Design:
The purpose of this study is to recruit and screen potential study subjects, mostly healthy volunteers, to determine if they are eligible for clinical trials of investigational products. This screening study also aims to characterize and analyze demographic information as well as laboratory and other medical findings in terms of how they may affect the eligibility of subjects for specific early phase clinical trials. All work will be conducted by the VRC Clinic of the National Institutes of Health or other IRB-approved sites that are collaborating with NIAID/VRC. Educational and recruitment materials on the investigational products and protocols will be
reviewed with and provided to subjects during participation in the screening protocol.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Healthy adults 18 - 60 years old |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To screen subjects for their eligibility to participate in clinical trials. | Duration of subject participation is variable, and may last from a few weeks to several months for each subject. | Ongoing |
Not provided
Not provided
Age: 18 years of age or older
Able and willing to complete the informed consent process
Agree to have blood and/or tissue samples collected and stored for future studies of investigational products, the immune system, and/or other medical conditions
EXCLUSION CRITERIA:
A condition in which repeated blood draws or injections pose more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access
A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being
Known to be pregnant or breast-feeding
Not provided
Not provided
Healthy volunteers
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| VRC Recruitment | Contact | (866) 833-5433 | vrcrecruitment@mail.nih.gov |
| Name | Affiliation | Role |
|---|---|---|
| Lasonji A Holman, C.R.N.P. | National Institute of Allergy and Infectious Diseases (NIAID) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Emory University | Completed | Atlanta | Georgia | 30030 | United States | |
| Univ of MD School of Medicine Center for Vaccine Development & Global Health |
Not provided
| Label | URL |
|---|---|
| NIH Clinical Center Detailed Web Page | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
| Active, not recruiting |
| Baltimore |
| Maryland |
| 21201-1595 |
| United States |
| National Institutes of Health Clinical Center | Recruiting | Bethesda | Maryland | 20892 | United States |
|
| University of Pennsylvania-UPenn | Completed | Philadelphia | Pennsylvania | 19104-6056 | United States |